Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Loans and Notes Receivables Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares Issued Shares Outstanding Shares Outstanding

Ratios

Terns Pharmaceuticals (TERN) Short-Term Debt repayments (2021)

Terns Pharmaceuticals' Short-Term Debt repayments history spans 1 years, with the latest figure at $12.9 million for Q1 2021.

For Q1 2021, Short-Term Debt repayments changed N/A year-over-year to $12.9 million; the TTM value through Dec 2021 reached $12.9 million, changed N/A, while the annual FY2021 figure was $12.9 million, N/A changed from the prior year.
Short-Term Debt repayments reached $12.9 million in Q1 2021 per TERN's latest filing.
In the past five years, Short-Term Debt repayments ranged from a high of $12.9 million in Q1 2021 to a low of $12.9 million in Q1 2021.